JP2005535594A5 - - Google Patents

Download PDF

Info

Publication number
JP2005535594A5
JP2005535594A5 JP2004506748A JP2004506748A JP2005535594A5 JP 2005535594 A5 JP2005535594 A5 JP 2005535594A5 JP 2004506748 A JP2004506748 A JP 2004506748A JP 2004506748 A JP2004506748 A JP 2004506748A JP 2005535594 A5 JP2005535594 A5 JP 2005535594A5
Authority
JP
Japan
Prior art keywords
heterocycle
aryl
occurrence
alkyl
independently selected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004506748A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005535594A (ja
Filing date
Publication date
Priority claimed from US10/443,263 external-priority patent/US20040034084A1/en
Application filed filed Critical
Publication of JP2005535594A publication Critical patent/JP2005535594A/ja
Publication of JP2005535594A5 publication Critical patent/JP2005535594A5/ja
Pending legal-status Critical Current

Links

JP2004506748A 2002-05-24 2003-05-23 疾患に関連した消耗を治療または予防するためのｊｎｋ阻害剤の使用方法 Pending JP2005535594A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38320202P 2002-05-24 2002-05-24
US10/443,263 US20040034084A1 (en) 2002-05-24 2003-05-22 Methods for using JNK inhibitors for treating or preventing disease-related wasting
PCT/US2003/016333 WO2003099221A2 (en) 2002-05-24 2003-05-23 Methods for using jnk inhibitors for treating or preventing disease-related wasting

Publications (2)

Publication Number Publication Date
JP2005535594A JP2005535594A (ja) 2005-11-24
JP2005535594A5 true JP2005535594A5 (https=) 2006-03-23

Family

ID=29586989

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004506748A Pending JP2005535594A (ja) 2002-05-24 2003-05-23 疾患に関連した消耗を治療または予防するためのｊｎｋ阻害剤の使用方法

Country Status (10)

Country Link
US (1) US20040034084A1 (https=)
EP (1) EP1507528A4 (https=)
JP (1) JP2005535594A (https=)
CN (1) CN1668299A (https=)
AU (1) AU2003256259A1 (https=)
CA (1) CA2487073A1 (https=)
IL (1) IL165359A0 (https=)
MX (1) MXPA04011599A (https=)
NZ (1) NZ537055A (https=)
WO (1) WO2003099221A2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4219289B2 (ja) * 2004-03-10 2009-02-04 独立行政法人科学技術振興機構 多環性ケトン化合物及びその製造方法
US20100009929A1 (en) 2004-03-29 2010-01-14 Cheng Jin Q Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof
US20100009928A1 (en) * 2004-03-29 2010-01-14 Cheng Jin Q Compositions including triciribine and taxanes and methods of use thereof
US20110008327A1 (en) 2004-03-29 2011-01-13 Cheng Jin Q Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof
MXPA06011219A (es) 2004-03-29 2007-05-08 Univ South Florida Tratamiento efectivo de tumores y cancer con triciribina y compuestos relacionados.
US20100173864A1 (en) 2004-03-29 2010-07-08 Cheng Jin Q Compositions including triciribine and one or more platinum compounds and methods of use thereof
US20100028339A1 (en) 2004-03-29 2010-02-04 Cheng Jin Q Compositions including triciribine and trastuzumab and methods of use thereof
AR050253A1 (es) * 2004-06-24 2006-10-11 Smithkline Beecham Corp Compuesto derivado de indazol carboxamida, composicion que lo comprende y su uso para la preparacion de un medicamento
WO2006010595A1 (en) * 2004-07-27 2006-02-02 Novartis Ag Inhibitors of hsp90
MX2007001155A (es) * 2004-07-29 2007-08-14 Creabilis Therapeutics Spa Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1.
EP1676574A3 (en) 2004-12-30 2006-07-26 Johnson & Johnson Vision Care, Inc. Methods for promoting survival of transplanted tissues and cells
WO2010009166A1 (en) 2008-07-14 2010-01-21 Gilead Colorado, Inc. Oxindolyl inhibitor compounds
US8124764B2 (en) 2008-07-14 2012-02-28 Gilead Sciences, Inc. Fused heterocyclyc inhibitor compounds
CA2729909A1 (en) 2008-07-14 2010-01-21 Gilead Sciences, Inc. Imidazolyl pyrimidine inhibitor compounds
CN102123987A (zh) 2008-07-28 2011-07-13 吉里德科学公司 亚环烷基和亚杂环烷基组蛋白脱乙酰酶抑制剂化合物
KR20120031170A (ko) 2009-06-08 2012-03-30 길리애드 사이언시즈, 인코포레이티드 알카노일아미노 벤즈아미드 아닐린 ｈｄａｃ 저해제 화합물
US8283357B2 (en) 2009-06-08 2012-10-09 Gilead Sciences, Inc. Cycloalkylcarbamate benzamide aniline HDAC inhibitor compounds
KR20160023669A (ko) * 2013-06-26 2016-03-03 자이겐 인플라메이션 리미티드 다양한 질병의 치료를 위한 jnk 신호 전달 경로의 세포 투과성 펩타이드 억제자의 새로운 용도

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3994890A (en) * 1974-01-31 1976-11-30 Chugai Seiyaku Kabushiki Kaisha 1-Aminoalkyl, 3-phenyl indazoles
US4198518A (en) * 1977-09-02 1980-04-15 Ciba-Geigy Corporation Process for the production of 3-substituted pyrazolanthrones
JPS57109787A (en) * 1980-12-26 1982-07-08 Chugai Pharmaceut Co Ltd Pyrazoloindazole derivative
US4788195A (en) * 1986-01-13 1988-11-29 American Cyanamid Company 4,5,6-substituted-N-(substituted-phenyl)-2-pyrimidinamines
US4973690A (en) * 1988-04-12 1990-11-27 Ciba-Geigy Corporation Novel ureas
US4966622A (en) * 1988-04-12 1990-10-30 Ciba-Geigy Corporation N-phenyl-N-pyrimidin-2-ylureas
JP2515162B2 (ja) * 1990-02-23 1996-07-10 富士写真フイルム株式会社 メチン化合物
GB9016449D0 (en) * 1990-07-26 1990-09-12 Ici Plc Anionic compounds
EP0514675B1 (en) * 1991-04-22 1999-12-08 Fuji Photo Film Co., Ltd. Silver halide photographic materials and method for processing the same
JP2692021B2 (ja) * 1991-09-13 1997-12-17 富士写真フイルム株式会社 ハロゲン化銀感光材料
US5516775A (en) * 1992-08-31 1996-05-14 Ciba-Geigy Corporation Further use of pyrimidine derivatives
WO1996004909A1 (en) * 1994-08-12 1996-02-22 Takeda Chemical Industries, Ltd. Use of quinone and hydroquinone derivatives for the teatment of cachexia
AP1147A (en) * 1996-05-03 2003-02-25 Pfizer Substituted indazole derivatives and related compounds.
US6162613A (en) * 1998-02-18 2000-12-19 Vertex Pharmaceuticals, Inc. Methods for designing inhibitors of serine/threonine-kinases and tyrosine kinases
US6897231B2 (en) * 2000-07-31 2005-05-24 Signal Pharmaceuticals, Inc. Indazole derivatives as JNK inhibitors and compositions and methods related thereto
US6987184B2 (en) * 2001-02-15 2006-01-17 Signal Pharmaceuticals, Llc Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof as JNK inhibitors and compositions and methods related

Similar Documents

Publication Publication Date Title
JP2005535594A5 (https=)
JP2005533748A5 (https=)
RU2007139634A (ru) Новые тиазол-, триазол- или оксадиазол-содержащие тетрациклические соединения
JP2008525417A5 (https=)
RU2009115963A (ru) Производные оксадиазола, обладающие противовоспалительными и иммунодепрессантными свойствами
JP2006515858A5 (https=)
RU2011103741A (ru) Композиции и способы лечения заболевания сетчатки
JP2007508359A5 (https=)
JP2005526144A5 (https=)
JP2006512143A5 (https=)
JP2005501120A5 (https=)
RU2009115784A (ru) Производные пиразоло[1,5-а]пиримидина и их применение в медицине
JP2006501292A5 (https=)
TW200745029A (en) Sulfonamide derivatives exhibiting PGD2 receptor antagonism
JP2007517044A5 (https=)
JP2012510523A5 (https=)
JP2007524696A5 (https=)
JP2014532060A5 (https=)
JP2011521911A5 (https=)
NO20072515L (no) 2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav
JP2005530811A5 (https=)
RU2012117395A (ru) Новые макроциклические ингибиторы репликации вируса гепатита с
JP2006511495A5 (https=)
JP2011526917A5 (https=)
JP2005525392A5 (https=)